DK489889D0 - Dihydropyridinamider, deres fremstilling og anvendelse i laegemidler - Google Patents

Dihydropyridinamider, deres fremstilling og anvendelse i laegemidler

Info

Publication number
DK489889D0
DK489889D0 DK489889A DK489889A DK489889D0 DK 489889 D0 DK489889 D0 DK 489889D0 DK 489889 A DK489889 A DK 489889A DK 489889 A DK489889 A DK 489889A DK 489889 D0 DK489889 D0 DK 489889D0
Authority
DK
Denmark
Prior art keywords
dihydropyridinamides
pharmaceuticals
preparation
Prior art date
Application number
DK489889A
Other languages
English (en)
Other versions
DK489889A (da
Inventor
Juergen Stoltefuss
Eckhard Schwenner
Rainer Gross
Siegbert Hebisch
Matthias Schramm
Claudia Hirth
Johannes-Peter Stasch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK489889D0 publication Critical patent/DK489889D0/da
Publication of DK489889A publication Critical patent/DK489889A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
DK489889A 1988-10-05 1989-10-04 Dihydropyridinamider, deres fremstilling og anvendelse i laegemidler DK489889A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3833892A DE3833892A1 (de) 1988-10-05 1988-10-05 Basische 4-aryl-dhp-amide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
DK489889D0 true DK489889D0 (da) 1989-10-04
DK489889A DK489889A (da) 1990-04-06

Family

ID=6364449

Family Applications (1)

Application Number Title Priority Date Filing Date
DK489889A DK489889A (da) 1988-10-05 1989-10-04 Dihydropyridinamider, deres fremstilling og anvendelse i laegemidler

Country Status (16)

Country Link
US (1) US5015650A (da)
EP (1) EP0362632A3 (da)
JP (1) JPH02169572A (da)
KR (1) KR900006289A (da)
CN (1) CN1041758A (da)
AU (1) AU616801B2 (da)
CA (1) CA2000081A1 (da)
DD (2) DD297813A5 (da)
DE (1) DE3833892A1 (da)
DK (1) DK489889A (da)
FI (1) FI894677A (da)
HU (1) HUT52055A (da)
IL (1) IL91863A0 (da)
NO (1) NO893756L (da)
PT (1) PT91884A (da)
ZA (1) ZA897532B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3833893A1 (de) * 1988-10-05 1990-04-12 Bayer Ag Verwendung von basischen nitro-phenyl-dihydropyridin-amiden als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung ueber neue zwischenprodukte
NL9001752A (nl) * 1990-08-02 1992-03-02 Cedona Pharm Bv Nieuwe 1,4-dihydropyridinederivaten.
DE4100125A1 (de) * 1991-01-04 1992-07-09 Bayer Ag Neue dihydropyridinamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
CN101802593B (zh) * 2007-09-25 2012-06-06 爱科来株式会社 分光测量用压片、其制造方法和分光测量方法
US10513515B2 (en) 2017-08-25 2019-12-24 Biotheryx, Inc. Ether compounds and uses thereof
AU2019309894A1 (en) 2018-07-27 2021-01-28 Biotheryx, Inc. Bifunctional compounds as CDK modulators
US11897930B2 (en) 2020-04-28 2024-02-13 Anwita Biosciences, Inc. Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2228377A1 (de) * 1972-06-10 1974-01-03 Bayer Ag Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
DE3445852A1 (de) * 1984-12-15 1986-06-19 Bayer Ag, 5090 Leverkusen Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3521761A1 (de) * 1985-06-19 1987-01-02 Bayer Ag Neue 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
JPS62174050A (ja) * 1985-10-21 1987-07-30 Nippon Shoji Kk ３−アミノカルボニル−１，４−ジヒドロピリジン−５−カルボン酸誘導体、その製法および医薬組成物
DE3601397A1 (de) * 1986-01-18 1987-07-23 Bayer Ag Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3711991A1 (de) * 1987-04-09 1988-10-20 Bayer Ag Dihydropyridinamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3833893A1 (de) * 1988-10-05 1990-04-12 Bayer Ag Verwendung von basischen nitro-phenyl-dihydropyridin-amiden als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung ueber neue zwischenprodukte

Also Published As

Publication number Publication date
FI894677A0 (fi) 1989-10-03
JPH02169572A (ja) 1990-06-29
CA2000081A1 (en) 1990-04-05
DD296683A5 (de) 1991-12-12
KR900006289A (ko) 1990-05-07
FI894677A (fi) 1990-04-06
NO893756D0 (no) 1989-09-21
EP0362632A3 (de) 1990-11-07
AU616801B2 (en) 1991-11-07
DE3833892A1 (de) 1990-04-12
HUT52055A (en) 1990-06-28
DK489889A (da) 1990-04-06
US5015650A (en) 1991-05-14
ZA897532B (en) 1990-06-27
DD297813A5 (de) 1992-01-23
PT91884A (pt) 1990-04-30
AU4260989A (en) 1990-04-12
IL91863A0 (en) 1990-06-10
EP0362632A2 (de) 1990-04-11
CN1041758A (zh) 1990-05-02
NO893756L (no) 1990-04-06

Similar Documents

Publication Publication Date Title
DK374389A (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
DK609489A (da) Imidazolderivater, deres fremstilling og anvendelse
DK273689D0 (da) 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
DK374289A (da) Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse
DK155489A (da) Umaettede n-benzopyranyllactamer, deres fremstilling og anvendelse
DK633689D0 (da) Benzothiazolin-derivater, deres fresmtilling og anvendelse i laegemidler
DK388989D0 (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
DK435289D0 (da) Piperazindioner, deres fremstilling og anvendelse
DK633489A (da) Benzothiazolin-derivater, deres fremstilling og anvendelse i laegemidler
DK633789A (da) Benzothiazol-derivater, deres fremstilling og anvendelse i laegemidler
DK489889A (da) Dihydropyridinamider, deres fremstilling og anvendelse i laegemidler
DK225089D0 (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
DK8589D0 (da) Pyrazol- og indazolpyridinaminer, deres fremstilling og anvendelse
NO902248L (no) Renininhiberende peptider, deres fremstilling og anvendelse i legemidler.
DK469389A (da) Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse
DK196389D0 (da) N-substituerede n-amino-pyrroler, deres fremstilling og anvendelse
DK592389D0 (da) Penemderivater, deres fremstilling og anvendelse
DK10487D0 (da) 4-aminoaryldihydropyridinlactoner, deres fremstilling og anvendelse i laegemidler
DK185489A (da) Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse
NO900275L (no) Benzopyranderivater, deres fremstilling og anvendelse i legemidler.
NO914653D0 (no) Substituerte dibenz-oksa-tiocinnoner, -12-oksyder og -12,12-dioksyder, deres fremstilling og anvendelse i legemidler
DK455189D0 (da) 2,3,4,5-tetrahydro-1-benzoxepiner, deres fremstilling og anvendelse
DK121089D0 (da) 1-substituerede 4-pentafluorphenoxypyridiner, deres fremstilling og anvendelse
DK163589D0 (da) Sakyomycin e og derivater deraf, deres fremstilling og anvendelse
DK578689D0 (da) Renin-haemmende dipeptider, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
ATS Application withdrawn